Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
D000818:Animals; D001545:Benserazide / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D002552:Cerebral Ventricles / Q000166:cytology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D007032:Hypothalamus, Anterior / Q000166:cytology; D008297:Male; D008636:Mesencephalon / Q000166:cytology; D009043:Motor Activity / Q000187:drug effects; D009411:Nerve Endings / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D009830:Olfactory Bulb / Q000166:cytology; D011301:Preoptic Area / Q000166:cytology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism
D002395:Catecholamines; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D012110:Reserpine; D004298:Dopamine; D009638:Norepinephrine